Cigarette smoking is the No. 1 risk factor for lung cancer. Exposure to second-hand smoke can also increase the risk of lung cancer. This is what scientists have known for a long time. What they did not know until now is ...
Nov 14, 2022
0
4
The largest study to investigate the tolerability of the breast cancer drug tamoxifen in male breast cancer patients has shown that men stop taking their prescribed therapy early because of problems with side effects caused ...
Nov 16, 2011
0
0
Tiny finger-like projections called filopodia drive invasive behavior in a rare subset of lung cancer cells, researchers at Winship Cancer Institute of Emory University have found.
Jul 27, 2020
0
67
Researchers have developed a method to analyze circulating tumor cells in the blood of patients with non-small cell lung cancer. This method, which can analyze a sample size as small as three cells, may allow clinicians to ...
Jan 9, 2012
0
0
In Nature Medicine, the seven comprehensive cancer centers of Cancer Core Europe (CCE), including the Netherlands Cancer Institute and Cancer Research UK Cambridge center, have shared how they rapidly reorganised their oncological ...
Apr 17, 2020
0
112
During involution -- the process during which milk-producing cells are killed and replaced by fat cells -- the breast is especially susceptible to the development of aggressive cancers. This study shows that NSAIDs like ibuprofen ...
Aug 11, 2011
0
0
A new study has shed light on how cancer patients' attitudes and beliefs drive the use of complementary and alternative medicine. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the ...
May 26, 2015
0
38
High-dose chemotherapy and autologous stem cell transplantation (HDC-ASCT), for previously untreated patients with advanced follicular lymphoma (FL) does not improve overall survival compared with conventional-dose chemotherapy ...
Dec 21, 2011
0
0
Half-matched bone marrow or stem cell transplants for blood cancer patients have typically been associated with disappointing clinical outcomes. However, a clinical trial conducted at the Kimmel Cancer Center at Jefferson ...
Sep 1, 2011
0
0
Patients with high-risk melanoma who received the immunotherapy drug pembrolizumab both before and after surgery to remove cancerous tissue had a significantly lower risk of their cancer recurring than similar patients who ...
Mar 1, 2023
0
12
